NCT00032903View on ClinicalTrials.gov

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

October 31, 2005

Conditions
Malignant Glioma
Interventions
DRUG

Gimatecan® (ST 1481)

Trial Locations (1)

02903

Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

lead

Sigma-Tau Research, Inc.

INDUSTRY

NCT00032903 - This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma. | Biotech Hunter | Biotech Hunter